Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

LifeStance Health (LFST) Cost of Revenue (2020 - 2024)

Historic Cost of Revenue for LifeStance Health (LFST) over the last 5 years, with Q3 2024 value amounting to $212.3 million.

  • LifeStance Health's Cost of Revenue rose 1371.55% to $212.3 million in Q3 2024 from the same period last year, while for Sep 2024 it was $829.8 million, marking a year-over-year increase of 1478.23%. This contributed to the annual value of $753.6 million for FY2023, which is 2105.04% up from last year.
  • Per LifeStance Health's latest filing, its Cost of Revenue stood at $212.3 million for Q3 2024, which was up 1371.55% from $214.5 million recorded in Q2 2024.
  • In the past 5 years, LifeStance Health's Cost of Revenue ranged from a high of $214.5 million in Q2 2024 and a low of $31.3 million during Q2 2020
  • Over the past 5 years, LifeStance Health's median Cost of Revenue value was $157.3 million (recorded in 2022), while the average stood at $151.5 million.
  • In the last 5 years, LifeStance Health's Cost of Revenue surged by 24961.15% in 2021 and then soared by 1241.84% in 2024.
  • Quarter analysis of 5 years shows LifeStance Health's Cost of Revenue stood at $68.8 million in 2020, then soared by 97.17% to $135.7 million in 2021, then rose by 22.78% to $166.7 million in 2022, then rose by 18.37% to $197.3 million in 2023, then grew by 7.6% to $212.3 million in 2024.
  • Its Cost of Revenue was $212.3 million in Q3 2024, compared to $214.5 million in Q2 2024 and $205.7 million in Q1 2024.